Nemaura Medical, Inc. (NMRD) earnings
Quarterly and annual NMRD reports and results, each read against the price at its own news timestamp. Back to the NMRD overview →
4 measured NMRD earnings events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form NT 10-K Nemaura Medical Inc. For: Mar 31 | SEC filing · Form NT | +57.90% | +41.05% | |
| Form 10-Q Nemaura Medical Inc. For: Dec 31 | SEC filing · Form 10-Q | +0.00% | -6.25% | |
| Form 10-Q Nemaura Medical Inc. For: Sep 30 | SEC filing · Form 10-Q | — | +4.60% | |
| Nemaura Medical Reports Fiscal Second Quarter 2024 Results and Provides Business Update | Press release | — | +4.60% |
Keep exploring
More NMRD: analyst actions → · SEC filings → · NMRD overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| AcelRx Pharmaceuticals, Inc. (ACRX) | 32 | +0.52% | 64% |
| Aravive, Inc. (ARAV) | 32 | +4.15% | 67% |
| Radius Recycling, Inc. - Class A (RDUS) | 32 | -0.14% | 38% |
| Ares Acquisition Corporation III (AAC) | 31 | 0.00% | 50% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.